[[Letterhead of NetEase.com, Inc.] September 30, 2009 Mr. H. Christopher Owings, Assistant Director Mr. John Fieldsend, Attorney-Adviser Division of Corporation Finance 100 F Street, NE Re: NetEase.com, Inc. (the Company) Annual Report on Form 20-F for the Year Ended December 31, 2008 Filed June 30, 2009 File No. 0-30666 (the 2008 Form 20-F) Dear Mr. Owings and Mr. Fieldsend: Letter]
[[Letterhead of NetEase.com, Inc.] September 30, 2009 Mr. H. Christopher Owings, Assistant Director Mr. John Fieldsend, Attorney-Adviser Division of Corporation Finance 100 F Street, NE Re: NetEase.com, Inc. (the Company) Annual Report on Form 20-F for the Year Ended December 31, 2008 Filed June 30, 2009 File No. 0-30666 (the 2008 Form 20-F) Dear Mr. Owings and Mr. Fieldsend: Letter]
[[Letterhead of NetEase.com,] September30, 2009 Mr.H. Christopher Owings,sistant Director Mr.John Fieldsend, Attorney-Adviser STYLE="font-family:Times New Roman" SIZE="2">Division ofrporation Finance 100 F Street, NE Re: NetEase.com, (thempany) Annual Report on Form 20-F for the Year Ended December31, 2008 Filed June30, 2009 File No. 0-30666 (the 2008 Form 20-F)]
[[Letterhead of NetEase.com,] September30, 2009 Mr.H. Christopher Owings,sistant Director Mr.John Fieldsend, Attorney-Adviser STYLE="font-family:Times New Roman" SIZE="2">Division ofrporation Finance 100 F Street, NE Re: NetEase.com, (thempany) Annual Report on Form 20-F for the Year Ended December31, 2008 Filed June30, 2009 File No. 0-30666 (the 2008 Form 20-F)]
[[Letterhead of NetEase.com,] September30, 2009 Mr.H. Christopher Owings,sistant Director Mr.John Fieldsend, Attorney-Adviser STYLE="font-family:Times New Roman" SIZE="2">Division ofrporation Finance 100 F Street, NE Re: NetEase.com, (thempany) Annual Report on Form 20-F for the Year Ended December31, 2008 Filed June30, 2009 File No. 0-30666 (the 2008 Form 20-F)]
[[Letterhead of NetEase.com,] September30, 2009 Mr.H. Christopher Owings,sistant Director Mr.John Fieldsend, Attorney-Adviser STYLE="font-family:Times New Roman" SIZE="2">Division ofrporation Finance 100 F Street, NE Re: NetEase.com, (thempany) Annual Report on Form 20-F for the Year Ended December31, 2008 Filed June30, 2009 File No. 0-30666 (the 2008 Form 20-F)]
[[Letterhead of NetEase.com,] September30, 2009 Mr.H. Christopher Owings,sistant Director Mr.John Fieldsend, Attorney-Adviser STYLE="font-family:Times New Roman" SIZE="2">Division ofrporation Finance 100 F Street, NE Re: NetEase.com, (thempany) Annual Report on Form 20-F for the Year Ended December31, 2008 Filed June30, 2009 File No. 0-30666 (the 2008 Form 20-F)]
[[Letterhead of NetEase.com,] September30, 2009 Mr.H. Christopher Owings,sistant Director Mr.John Fieldsend, Attorney-Adviser STYLE="font-family:Times New Roman" SIZE="2">Division ofrporation Finance 100 F Street, NE Re: NetEase.com, (thempany) Annual Report on Form 20-F for the Year Ended December31, 2008 Filed June30, 2009 File No. 0-30666 (the 2008 Form 20-F)]
[I. SINOVAC REPORTS UNAUDITED SECOND QUARTER 2009 FINANCIAL RESULTS - Conference call scheduled Wednesday, August 19, 2009 at 8:00 a.m. ET - - Reaffirmation of 2009 sales projection to be $55 million to $60 million - - H1N1 vaccine may drive additional growth - BEIJING, Aug. 19 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE Amex: SVA), a leading developer and provider] [FORM 6-K __________ __________ SINOVAC BIOTECH LTD. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China X Form 20-F X Yes _______ No N/A 82- SINOVAC BIOTECH LTD. Form 6-K TABLE OF CONTENTS Page 3 4]
[I. SINOVAC REPORTS UNAUDITED SECOND QUARTER 2009 FINANCIAL RESULTS - Conference call scheduled Wednesday, August 19, 2009 at 8:00 a.m. ET - - Reaffirmation of 2009 sales projection to be $55 million to $60 million - - H1N1 vaccine may drive additional growth - BEIJING, Aug. 19 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE Amex: SVA), a leading developer and provider] [FORM 6-K __________ __________ SINOVAC BIOTECH LTD. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China X Form 20-F X Yes _______ No N/A 82- SINOVAC BIOTECH LTD. Form 6-K TABLE OF CONTENTS Page 3 4]
